综述

小柴胡汤在妇科疾病中的临床应用进展

Progress in the clinical application of Xiaochaihu Decoction in gynecological diseases

:413-418
 
       小柴胡汤是《伤寒杂病论》中的一首经典方剂,是和解法的基础方,后世将其广泛用于治疗妇科疾病。本研究旨在通过文献检索,探讨小柴胡汤在治疗妇科疾病方面的有效性及其应用的最新进展。文章综述了小柴胡汤在治疗妇科痛证、血证、带下证、块证等相关疾病方面的临床研究和实践经验。小柴胡汤通过其疏肝利胆、健运脾胃、和解枢机的作用,有效改善了女性痛经、盆腔炎性疾病、月经不调、妇科肿瘤、围绝经期综合征等妇科疾病症状。作为临床常用的妇科学方剂,小柴胡汤亟需进一步的发扬与创新,以期更有效地应用于未来的临床实践。
    Xiaochaihu Decoction,as a classic prescription in the Treatise on Cold Pathogenic and Miscellaneous Diseases,laid the foundation for reconciliation.It has a wide range of applications in the treatment of gynecological diseases.Through a literature search,this study aimed to explore the effectiveness of Xiaochaihu Decoction in the treatment of gynecological diseases and the latest progress of its application.This article reviews the clinical research and practical experience of Xiaochaihu Decoction in the treatment of gynecological pain,bleeding,leucorrhea disease,tumors and other related diseases.Xiaochaihu Decoction has effectively improved the symptoms of gynecological diseases such as dysmenorrhea,pelvic inflammatory disease,menstrual irregularities,gynecological tumors,and perimenopausal syndrome through its role of soothing the liver and promoting bile flow,strengthening the spleen and stomach,and harmonizing and releasing the pivot.As a commonly used gynecological prescription in clinical practice,Xiaochaihu Decoction urgently needs to be further developed and innovated to be more effectively applied to clinical practice in the future.

顺行输尿管软镜治疗特殊类型输尿管中下段梗阻的临床应用

Clinical Application of Retrograde Ureteroscopic Treatment for Special Types of middle and lower Ureteral Obstruction

:-
 
目的 探讨顺行输尿管软镜治疗特殊类型输尿管中下段梗阻的临床疗效。方法 分析2024年1月至2026年5月广东省中西医结合医院收治了20例特殊类型输尿管中下段梗阻患者的临床资料,对患者手术时间、术前和术后的血红蛋白、肾积水及随访情况进行分析。结果 所有患者均一期完成手术,手术时间为(75.5±16.4)分钟,术前与术后第一天血红蛋白对比,有一定差异(t=6.141,P<0.05),术前与术后1个月患侧肾积液对比,肾积液明显改善(t=3.937,P<0.05)。结论 经皮肾通道顺行输尿管软镜治疗特殊类型输尿管中下段梗阻具有微创、安全、有效、并发症少、术后恢复快等优点,值得临床推广应用。
Objective To evaluate the clinical efficacy of antegrade flexible ureteroscopy in treating special types of middle and lower ureteral obstruction. Methods From January 2024 to May 2026, clinical data of 20 patients with special types of middle and lower ureteral obstruction admitted to Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine were analyzed. The operation time, preoperative and postoperative hemoglobin levels, hydronephrosis, and follow-up conditions of the patients were analyzed. Results All patients underwent successful single-stage surgery, with an average operative time of (75.5 ± 16.4) minutes. There was a significant difference in hemoglobin levels between preoperatively and on the first postoperative day (t = 6.141, P < 0.05). Hydronephrosis on the affected side showed marked improvement when comparing preoperative and one-month postoperative conditions (t = 3.937, P < 0.05). Conclusions Antegrade flexible ureteroscopy via percutaneous nephrostomy tract is a minimally invasive, safe, effective, and well-tolerated approach for treating special types of middle and lower ureteral obstruction, with few complications and rapid postoperative recovery, making it worthy of clinical promotion and application.

顺行输尿管软镜治疗特殊类型输尿管中下段梗阻的临床应用

Clinical Application of Retrograde Ureteroscopic Treatment for Special Types of middle and lower Ureteral Obstruction

:-
 
目的 探讨顺行输尿管软镜治疗特殊类型输尿管中下段梗阻的临床疗效。方法 分析2024年1月至2026年5月广东省中西医结合医院收治了20例特殊类型输尿管中下段梗阻患者的临床资料,对患者手术时间、术前和术后的血红蛋白、肾积水及随访情况进行分析。结果 所有患者均一期完成手术,手术时间为(75.5±16.4)分钟,术前与术后第一天血红蛋白对比,有一定差异(t=6.141,P<0.05),术前与术后1个月患侧肾积液对比,肾积液明显改善(t=3.937,P<0.05)。结论 经皮肾通道顺行输尿管软镜治疗特殊类型输尿管中下段梗阻具有微创、安全、有效、并发症少、术后恢复快等优点,值得临床推广应用。
Objective To evaluate the clinical efficacy of antegrade flexible ureteroscopy in treating special types of middle and lower ureteral obstruction. Methods From January 2024 to May 2026, clinical data of 20 patients with special types of middle and lower ureteral obstruction admitted to Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine were analyzed. The operation time, preoperative and postoperative hemoglobin levels, hydronephrosis, and follow-up conditions of the patients were analyzed. Results All patients underwent successful single-stage surgery, with an average operative time of (75.5 ± 16.4) minutes. There was a significant difference in hemoglobin levels between preoperatively and on the first postoperative day (t = 6.141, P < 0.05). Hydronephrosis on the affected side showed marked improvement when comparing preoperative and one-month postoperative conditions (t = 3.937, P < 0.05). Conclusions Antegrade flexible ureteroscopy via percutaneous nephrostomy tract is a minimally invasive, safe, effective, and well-tolerated approach for treating special types of middle and lower ureteral obstruction, with few complications and rapid postoperative recovery, making it worthy of clinical promotion and application.

改良拔尿管方法在妇科腹腔镜术后患者临床应用研究

:-
 
探讨改良拔尿管方法在妇科腹腔镜术后留置尿管患者临床的影响。方法 选取2025年2月7日—2025年10 月10日我院妇科腹腔镜手术术后留置尿管患者60例为研究对象。本研究采用随机数字表法将研究对象分为对照组与观察组,两组各纳入30例。比较两组首次拔管尿路疼痛评价、首次排尿时间、患者尿潴留例数。结果 观察组首次拔尿管尿路疼痛程度显著低于对照组,两组差异有统计学意义(P<0.05)。观察组首次排尿时间显著少于对照组,两组差异有统计学意义(P<0.05)。观察两组尿潴留发生率差异无统计学意义(P>0.05)。结论 本次研究采用改良后的尿管拔除方法,虽未明显降低妇科腹腔镜术后患者的尿潴留发生率,但能有效降低拔尿管时患者的不适感 ,减少尿道损伤,缓解疼痛,加快患者自主排尿,具有积极临床实践意义。

改良拔尿管方法在妇科腹腔镜术后患者临床应用研究

:-
 
探讨改良拔尿管方法在妇科腹腔镜术后留置尿管患者临床的影响。方法 选取2025年2月7日—2025年10 月10日我院妇科腹腔镜手术术后留置尿管患者60例为研究对象。本研究采用随机数字表法将研究对象分为对照组与观察组,两组各纳入30例。比较两组首次拔管尿路疼痛评价、首次排尿时间、患者尿潴留例数。结果 观察组首次拔尿管尿路疼痛程度显著低于对照组,两组差异有统计学意义(P<0.05)。观察组首次排尿时间显著少于对照组,两组差异有统计学意义(P<0.05)。观察两组尿潴留发生率差异无统计学意义(P>0.05)。结论 本次研究采用改良后的尿管拔除方法,虽未明显降低妇科腹腔镜术后患者的尿潴留发生率,但能有效降低拔尿管时患者的不适感 ,减少尿道损伤,缓解疼痛,加快患者自主排尿,具有积极临床实践意义

重复经颅磁刺激治疗意识障碍的临床应用研究综述

:-
 
意识障碍(Disorders of Consciousness, DoC)是颅脑损伤、脑卒中、缺血缺氧性脑病等严重脑损伤后的常见并发症,其康复治疗是神经科学领域的重大挑战。重复经颅磁刺激(Repetitive Transcranial Magnetic Stimulation, rTMS)作为一种无创神经调控技术,通过调节皮层兴奋性、促进神经可塑性及改善脑血流灌注,在DoC治疗中展现出独特优势。本文系统梳理近年研究,从作用机制、临床证据及未来方向等方面进行综述,旨在为临床精准治疗提供理论依据。
论著

脊髓损伤神经功能评估系统的优化和临床应用效果分析

Optimized design and clinical efficacy analysis of neural function evaluation system for spinal cord injury

:1415-1422
 
目的 优化纸质版脊髓损伤神经功能评估系统, 探讨其在脊柱脊髓损伤患者临床管理中的实际应用效果。方法 广泛检索国内外关于脊柱脊髓损伤患者神经运动功能评估的文献, 结合课题组成员的临床经验, 初步筛选出神经运动功能评估的关键项目。通过两轮德尔菲专家函询, 确定评估项目内容, 对纸质版脊髓损伤神经功能评估系统进行优化, 并进行临床应用验证。选取2021年8月1日—2023年5月31日在广州市第一人民医院脊柱外科住院的120例脊柱脊髓疾病患者作为研究对象, 随机分为观察组和对照组。对比两组在应用优化前后评估系统的神经功能评估准确性、评估所需时间以及临床应用便捷性等方面的差异。结果 观察组的评估准确性显著高于对照组,错评率由20.3%降至4.7%,漏评率由32.0%降至5.0%; 此外,优化后的评估系统显著缩短了评估时间,平均减少6.0 min, 有效提升了评估效率。结论 优化后的脊髓损伤神经功能评估系统显著提高了评估的准确性和效率, 有效减少了主观误差。
Objective To refine and optimize the paper-based assessment tool for evaluating neurological function in spinal cord injury patients, and to explore its impact on clinical practice.Methods A comprehensive review of existing literature on neuromotor function assessment in spinal cord injury patients was conducted, complemented by discussions among members of this study.This led to the integration of a preliminary evaluation framework.Subsequently, a two-round Delphi consensus process involving experts was undertaken to finalize the content of the assessment project.Based on this, a paper-based evaluation system was developed and converted into an electronic format by computer professionals.This system was then tested in a clinical setting, where it was administered to 120 spinal cord injury patients at the Spine Surgery Department of Guangzhou First People’s Hospital between 1 August 2021 and 31 May 2023.Patients were randomly assigned to either an experimental group or a control group, allowing for a comparison of accuracy, efficiency, and convenience in clinical application.Results The experimental group demonstrated a notable improvement in assessment accuracy over the control group, with a significant reduction in error rate from 20.3% to 4.7% and a decrease in omission rate from 32.0% to 5.0%.Furthermore, the average assessment time was shortened by 6.0 minutes, markedly enhancing the efficiency of the evaluation process.Conclusions The optimized neurological function assessment system for spinal cord injury patients has proven effective in enhancing both the accuracy and efficiency of assessments, while significantly minimizing subjective errors.This system holds considerable potential for widespread clinical adoption and application.
论著

婴儿孤独症观察量表中文版的临床应用研究

Clinical application of the Chinese version of the Autism Observation Scale for Infants

:360-364
 
目的 检验婴儿孤独症观察量表中文版(AOSI)临床应用的灵敏度与特异度,评价其临床应用效果。方法 随机抽取1岁时曾在清远市妇幼保健院行AOSI评估,于2~3岁时诊断为孤独症谱系障碍(ASD)的48例患儿为ASD组,诊断为正常发展的46例幼儿作为对照组。比较两组患儿的18个条目得分和总分,采用受试者操作特征(ROC)曲线计算AOSI的特异度、灵敏度、阳性预测值与阴性预测值,并判断AOSI的最佳诊断(阳性)分界值;分析AOSI评估结果与《精神障碍诊断与统计手册(第5版)》(DSM-5)中ASD诊断标准的一致性。结果 两组研究对象性别、年龄比较差异无统计学意义(P>0.05)。ASD组各条目得分和总分均高于对照组,且差异具有统计学意义(P<0.01)。AOSI的曲线下面积(AUC)为1.00(P<0.01),95%置信区间为(1.00,1.00)。不同阳性分界线的灵敏度、特异度、阳性预测值、阴性预测值及一致性相比较,当约登指数等于1.00时AOSI的最佳诊断(阳性截断值)界线为9分时,其上述值均为1.00。AOSI评估结果与DSM-5中ASD的诊断标准完全相一致(Kappa=1,P<0.01)。结论 AOSI应用于评估1岁的婴儿,当取9分为诊断界值时,具有高度的灵敏度与特异度,能较好地预测该婴儿在2~3岁时是否患ASD;AOSI是婴儿期ASD筛查的重要工具,其评估结果可作为ASD高危儿早期干预的证据和ASD的辅助诊断工具,适合于临床推广应用。
Objective To test the sensitivity and specificity of the Chinese version of the Autism Observation Scale for Infants(AOSI)in clinical application and evaluate its clinical application effect.Methods Forty-eight children with autism spectrum disorder(ASD)diagnosed at the age of 2 to 3 years who had undergone AOSI evaluation in Qingyuan Maternal and Child Health Hospital at the age of 1 year(2021)were randomly selected as the ASD group,and 46 children with normal development were randomly selected as the control group.The scores of 18 items and total scores of the two groups of subjects were compared.The specificity,sensitivity,positive predictive value and negative predictive value of AOSI were calculated using the receiver operating characteristic curve(ROC),and the best diagnostic(positive)cut-off value of AOSI was confirmed.The consistency of AOSI evaluation results with the ASD diagnostic criteria in DSM-5 were compared.Results There was no statistically significant difference in genders or age between two groups(P>0.05).The scores of each item and total scores in the ASD group were significantly higher than those in the control group,and the difference was statistically significant(P<0.01).The area under the curve of AOSI(AUC=1.00,P<0.01)had a 95% confidence interval of(1.00,1.00).Comparing the sensitivity,specificity,positive predictive value,negative predictive value and consistency of different positive boundary points,when the Youden index was equal to 1.00,the optimal diagnostic(positive cut-off value)boundary for AOSI was 9 points,and all of the above values were 1.00. The AOSI evaluation results were completely consistent with the diagnostic criteria for ASD in DSM-5(Kappa=1,P<0.01).Conclusions AOSI has high sensitivity and specificity when it is used to evaluate the 1-year-old infant.When “9 points” is taken as the diagnostic threshold,it can better predict whether the infant has ASD at the age of 2~3 years.AOSI is an important tool for screening ASD in infancy.Its evaluation results can be used as evidence for early intervention of high-risk infants with ASD and as a assisting tool to diagnosis ASD,which is suitable for clinical application.
中医研究

中药配伍禁忌十八反临床应用启示

Enlightenment on the clinical application of Eighteen Antagonisms contraindications to the compatibility of Traditional Chinese Medicine

:1117-1121
 
前人总结的用药禁忌十八反未必是绝对禁忌,笔者从广东省名中医陈国成主任独创星夏止痛膏外治中得到反药“乌头-半夏”的配伍启示。本文简要叙述反药配伍的源流及应用,重点对陈国成使用乌头配半夏外用的经验及思路进行论述,认为乌头与半夏配伍可通过多种方式减毒增效,为临床安全使用该配伍药物提供新的思路。
The eighteen antagonisms summarized by predecessors may not be absolute contraindications.The author obtained the inspiration of the antagonism medicinals “aconite-pinellia” from the external treatment of Xingxia painkiller ointment created by Chen Guocheng.The present paper provides a concise overview of the origin and application of anti-drug compatibility,with a specific focus on Chen Guocheng's expertise and insights regarding the external use of aconite combined with pinellia.It is postulated that diverse approaches can be employed to modulate the compatibility between aconite and pinellia,thereby offering novel perspectives for ensuring the safe utilization of this drug combination in clinical practice.
综述

骨劈开术在水平骨量不足缺牙区种植中的临床应用进展

Clinical application review of bone splitting in dental implant for horizontal bone deficiency

:99-105
 
缺牙区水平骨量不足一直是口腔种植的重要难题。骨劈开术是常用于解决此难题的手术方式之一,目前临床常用术式是采用超声骨刀沿牙槽嵴顶矢状劈开后,用骨凿将唇(颊)侧骨板向唇(颊)侧移位后增加牙槽骨水平宽度,达到同期种植的目的。骨劈开并同期植入种植体降低了困难病例的手术难度和风险,减少了患者就诊次数,降低患者成本。但若劈开后种植体周围的间隙大于1 mm或唇侧骨板分离,则需要同期进行植骨。但骨劈开术的使用也具有一定的适应症,要求缺牙区垂直骨高度足够,水平骨宽度不足(3~5 mm),骨质为Ⅲ ~ Ⅳ类骨,患者无种植手术的局部和全身禁忌证。近年来的研究表明骨劈开术具有创伤小、手术安全有效、不用开辟第二创口即可获得较好的骨增量效果等优点,一定程度上扩大了种植手术适应证。现本文对骨劈开术的翻瓣术式、非翻瓣术式及术后效果的进展进行综述。
The insufficient horizontal bone mass in the missing tooth area has always been an important problem of dental implant. Bone splitting is one of the surgical methods commonly used to solve this problem. At present, the commonly used surgical method is to use ultrasonic bone knife to sagittal splitting along the crest of the alveolar ridge, and then use bone chisel to shift the lateral bone plate of the lip (buccal) to the lip (buccal) to increase the horizontal width of the alveolar bone, so as to achieve the purpose of simultaneous implantation. Bone splitting and implantation of implants in the same period reduced the surgical difficulty and risk of difficult cases, reduced the number of patient visits, and reduced the cost of patients. However, if the gap around the implant was more than 1 mm or the labial bone plate was separated after splitting, bone grafting should be performed simultaneously. But the use of bone splitting technique also has a certain indications, demanding sufficient vertical bone height in the missing area, inadequate width of horizontal bone (3 mm to 5 mm), Ⅲ~Ⅳ class bone, without local and systemic contraindicated of planting surgery. In recent years, the research shows that bone splitting surgery has the advantages of small trauma, safe and effective operation, and better bone increment effect obtained without opening the second wound. This article reviewed the progress of flap operation, flapless operation and postoperative effect of bone splitting.
出版者信息








《广州医药》公众号